Invasion and metastasis: biology and clinical potential
1Medicine Branch, National Cancer Institute, Bethesda, MD 20892.
Abstract:
Metastatic dissemination of tumor is the primary cause of death for most cancer patients. The expanding field of study of the metastatic cascade has been the source of novel approaches to the diagnosis and treatment of cancer. The metastatic process involves angiogenesis, tumor cell adhesion to vascular basement membrane, local proteolysis to create an opening in the basement membrane, migration through that rent and into the secondary site, and finally, successful proliferation. Important components of the metastatic cascade such as basement membrane structures, adhesion molecules and their receptors, proteolytic enzymes, migration-inducing factors, and growth factors have been demonstrated to have reproducible patterns in malignant and metastatic tissues. These patterns have led to clinical correlations demonstrating their utility in the identification and follow-up of malignant and metastatic disease. In addition, several promising new anti-cancer drugs such as inhibitors of angiogenesis, protease-inhibitors, and blockers of signal transduction have been identified and are awaiting introduction into the clinical arena.
Insights
Understanding tumor metastasis, the main cause of cancer death, reveals new diagnostic and treatment strategies. Research into the metastatic cascade identifies key molecular targets for novel anti-cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Medicine
Background:
- Tumor metastasis is the leading cause of cancer-related mortality.
- The metastatic cascade involves complex cellular and molecular processes.
- Understanding these processes offers opportunities for novel cancer therapies.
Purpose of the Study:
- To review the key molecular components and processes of the metastatic cascade.
- To highlight the clinical relevance of these components in cancer diagnosis and follow-up.
- To discuss emerging anti-cancer drug targets based on metastatic pathways.
Main Methods:
- Review of literature on tumor metastasis and the metastatic cascade.
- Analysis of molecular patterns in malignant and metastatic tissues.
- Correlation of molecular findings with clinical outcomes.
- Identification of potential therapeutic targets and drug candidates.
Main Results:
- Identified reproducible molecular patterns in metastatic tissues related to angiogenesis, cell adhesion, proteolysis, migration, and proliferation.
- Established clinical correlations demonstrating the utility of these patterns in identifying and monitoring malignant and metastatic disease.
- Highlighted several promising drug classes, including angiogenesis inhibitors, protease inhibitors, and signal transduction blockers.
Conclusions:
- The study of the metastatic cascade provides critical insights into cancer progression.
- Molecular patterns within the cascade are valuable for clinical applications in cancer management.
- Emerging therapeutic strategies targeting the metastatic cascade hold significant promise for future cancer treatment.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...


